lobbying_activities: 3201006

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3201006	07a0253f-f196-44c9-817b-c84d839f7466	Q2	MEHLMAN CONSULTING, INC.	284950	WEDGEWOOD PHARMACY LLC	2024	second_quarter	PHA	Issues related to animal drug compounding. Issues related to FDA's CVM GFI #256 - Compounding Animal Drugs from Bulk Substances.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2024-07-18T16:58:39-04:00